| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/04/2000 | US6010883 Recombinant fusion proteins |
| 01/04/2000 | US6010882 Production of biologically active recombinant insulin-like growth factor II polypeptides |
| 01/04/2000 | US6010881 Useful to screen compounds for antibiotic activity. polynucleotides that encode ribg polypeptides |
| 01/04/2000 | US6010880 Inhibitors of human plasmin derived from the kunitz domains |
| 01/04/2000 | US6010879 Polynucleotides encoding human mitochondrial chaperone proteins |
| 01/04/2000 | US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6 |
| 01/04/2000 | US6010877 cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor |
| 01/04/2000 | US6010876 Clavanins |
| 01/04/2000 | US6010875 Expressions plasmids containing the deo promoter, and bacterial hosts containing the plasmids |
| 01/04/2000 | US6010874 Early onset alzheimer's disease gene and gene products |
| 01/04/2000 | US6010873 Modified complement system regulators |
| 01/04/2000 | US6010872 Recombinant production of TGF-β type III receptor (betaglycan) polypeptides |
| 01/04/2000 | US6010865 Process for detecting a variant CD44 gene product |
| 01/04/2000 | US6010861 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 01/04/2000 | US6010860 Method for site-specific integration of nucleic acids and related products |
| 01/04/2000 | US6010859 RAB protein |
| 01/04/2000 | US6010858 Method for expression cloning of gene encoding protein kinase substrate protein |
| 01/04/2000 | US6010855 Desaturase antigen of mycobacterium tuberculosis |
| 01/04/2000 | US6010853 Siva genes, novel genes involved in CD27-mediated apoptosis |
| 01/04/2000 | US6010851 Method for producing nucleoside-5'-phosphate ester |
| 01/04/2000 | US6010850 Analysis of gene expression by display of 3'-end restriction fragments of cDNAs |
| 01/04/2000 | US6010849 Sequence-directed DNA binding molecules compositions and methods |
| 01/04/2000 | US6010848 Screening methods using an atpase protein from hepatitis C virus |
| 01/04/2000 | US6010704 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 01/04/2000 | US6010700 Polypeptides p57 or p9.5 of Borna disease virus and their use for diagnosis and immunization |
| 01/04/2000 | US6010694 Fibrillin 1 gene comprising duplication mutation and compositions and kits using the same |
| 01/04/2000 | CA2045658C Polypeptides having a .beta.-adremergic receptor activity in humans, involved_in the lipolytic response, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of active substances on these polypeptides |
| 01/04/2000 | CA1340869C T cell activation markers |
| 01/04/2000 | CA1340867C Expression plasmids for improved production of heterologus protein in bacteria |
| 01/03/2000 | CA2242116A1 Method for genetic engineering of disease resistance using the dr206 class of proteins |
| 01/02/2000 | CA2277594A1 (s)- hydroxynitrile lyases with improved substrate acceptance and their use |
| 12/30/1999 | DE19828850A1 New sphingolipid desaturase that selectively introduces double bond into sphingolipids and capnoids |
| 12/30/1999 | DE19828377A1 A transgenic non-human mammal expressing immunoglobulin E heavy chain, useful for testing of anti-human IgE antibodies |
| 12/30/1999 | DE19828097A1 Identifying antiparasitic agents used to treat or prevent parasitic infections, especially malaria, sleeping sickness and leishmaniosis |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067628A1 Multi-sensor array for electrochemical recognition of nucleotide sequences and methods |
| 12/29/1999 | WO1999067428A2 Method for detection of drug-selected mutations in the hiv protease gene |
| 12/29/1999 | WO1999067427A1 Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 12/29/1999 | WO1999067422A1 Method for detecting, analyzing, and mapping rna transcripts |
| 12/29/1999 | WO1999067415A1 Novel molecules of the t110-related protein family and uses thereof |
| 12/29/1999 | WO1999067414A1 Nucleotide detection method |
| 12/29/1999 | WO1999067413A1 Production of polymers from nucleotidic and/or non-nucleotidic elements using enzymatic methods |
| 12/29/1999 | WO1999067407A2 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 12/29/1999 | WO1999067406A1 Plant selectable marker and plant transformation method |
| 12/29/1999 | WO1999067405A2 Leafy cotyledon1 genes and their uses |
| 12/29/1999 | WO1999067404A1 Alteration of hemicellulose concentration in plants by rgp |
| 12/29/1999 | WO1999067403A1 Diacylglycerol o-acyltransferase |
| 12/29/1999 | WO1999067402A2 Methods to screen herbicidal compounds utilizing air synthetase from arabidopsis thaliana |
| 12/29/1999 | WO1999067401A2 Non-food crop plant bioreactor |
| 12/29/1999 | WO1999067400A1 Tissue-specific and target rna-specific ribozymes |
| 12/29/1999 | WO1999067399A1 HUMAN GLYCOPROTEASE-LIKE PROTEINS AND DNAs ENCODING THESE PROTEINS |
| 12/29/1999 | WO1999067398A2 Overexpression of phytase genes in yeast systems |
| 12/29/1999 | WO1999067397A1 De novo dna cytosine methyltransferase genes, polypeptides and uses thereof |
| 12/29/1999 | WO1999067396A1 Hcv-derived rna polymerase gene |
| 12/29/1999 | WO1999067395A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 12/29/1999 | WO1999067394A1 Vector expressing the full-length gene of rna virus and use thereof |
| 12/29/1999 | WO1999067393A2 Aav scleroprotein, production and use thereof |
| 12/29/1999 | WO1999067392A2 Modified plant metabolism using pyrophosphate-dependent phosphofructokinase |
| 12/29/1999 | WO1999067391A1 Origin of replication and methods of use |
| 12/29/1999 | WO1999067390A1 IMPROVED PROCESS FOR THE PRODUCTION OF β-LACTAMS |
| 12/29/1999 | WO1999067389A2 Cryptic regulatory elements obtained from plants |
| 12/29/1999 | WO1999067388A1 Antisense oligonucleotide inhibiting the expression of il-10 protein |
| 12/29/1999 | WO1999067387A2 Novel mp-7 protein and nucleic acid molecules and uses therefor |
| 12/29/1999 | WO1999067386A2 Differentially expressed genes in pancreatic cancer and displasia |
| 12/29/1999 | WO1999067385A1 Novel msp-5 protein and nucleic acid molecules and uses therefor |
| 12/29/1999 | WO1999067384A2 Prostate cancer-associated genes |
| 12/29/1999 | WO1999067383A1 Novel g protein-coupled receptor protein, dna and use thereof |
| 12/29/1999 | WO1999067382A2 Angiopoietin-like growth factor sequences |
| 12/29/1999 | WO1999067381A1 Treatment of staphylococcus infections |
| 12/29/1999 | WO1999067379A2 Structured antisense nucleic acid molecules |
| 12/29/1999 | WO1999067378A1 ANTISENSE OLIGONUCLEOTIDE CONSTRUCTS BASED ON β-ARABINOFURANOSE AND ITS ANALOGUES |
| 12/29/1999 | WO1999067377A1 Human arf-related proteins |
| 12/29/1999 | WO1999067376A1 Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides |
| 12/29/1999 | WO1999067375A2 Screening system |
| 12/29/1999 | WO1999067374A1 Methods for transferring the capability to produce a natural product into a suitable production host |
| 12/29/1999 | WO1999067373A2 Invertebrate intestinal mucins, cdnas, antibodies and their use |
| 12/29/1999 | WO1999067369A1 Cell cycle regulatory factor |
| 12/29/1999 | WO1999067367A1 DNA ENCODING OAT ACETYL CoA CARBOXYLASE |
| 12/29/1999 | WO1999067366A1 Surface expression system of hepatitis b virus surface antigen and core antigen of hepatitis c virus by using ice-nucleation protein |
| 12/29/1999 | WO1999067364A1 Method and medium for in vitro culture of human embryos |
| 12/29/1999 | WO1999067361A1 Allelic series of genomic modifications in cells |
| 12/29/1999 | WO1999067359A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 12/29/1999 | WO1999067358A2 Method of preparing objects containing dna |
| 12/29/1999 | WO1999067357A2 Transformation of monocots by co-cultivating an inflorescence with agrobacterium |
| 12/29/1999 | WO1999067356A2 Propionibacterium vector |
| 12/29/1999 | WO1999067293A1 Peptide composition as immunogen for the treatment of allergy |
| 12/29/1999 | WO1999067291A2 Site specific protein modification by mutagenesis |
| 12/29/1999 | WO1999067290A1 Novel hemopoietin receptor proteins |
| 12/29/1999 | WO1999067285A1 Particles of hcv envelope proteins: use for vaccination |
| 12/29/1999 | WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 12/29/1999 | WO1999067282A2 Olfactory receptors and their uses |
| 12/29/1999 | WO1999067269A1 Nucleic acid molecule encoding an ankyrin repeat tvl-1 protein and methods of use thereof |
| 12/29/1999 | WO1999067268A1 Diacylglycerol o-acyltransferase |
| 12/29/1999 | WO1999066959A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 12/29/1999 | WO1999066950A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
| 12/29/1999 | WO1999066875A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
| 12/29/1999 | WO1999066785A1 Water stress or salt stress tolerant transgenic cereal plants |
| 12/29/1999 | WO1999060147A3 Targeted delivery through a cationic amino acid transporter |
| 12/29/1999 | WO1999060133A3 Human nucleic acid methylases |
| 12/29/1999 | WO1999058681A3 Transgenic plant cells expressing a recombinant plant e2f peptide |